Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $9.02 USD
Change Today +0.03 / 0.33%
Volume 756.6K
NVAX On Other Exchanges
Symbol
Exchange
Frankfurt
As of 12:09 PM 05/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

James F. Young Ph.D.

Chairman, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee, Novavax, Inc.
AgeTotal Calculated CompensationThis person is connected to 47 board members in 4 different organizations across 6 different industries.

See Board Relationships
61$391,038

Background*

Dr. James F. Young, also known as Jim, Ph.D., is a Professor and Chairman, Academic Department of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University and Chairman, Endocrinology and Metabolism Institute. Dr. Young also serves as a Physician Director of Institutional Relations and Development and a Medical Director of the Kaufman Center for Heart Failure. Dr. Young served as the President, Research and Development of MedImmune LLC ...

Read Full Background

Corporate Headquarters*

20 Firstfield Road
Gaithersburg, Maryland 20878

United States

Phone: 240-268-2000
Fax: --

Board Members Memberships*

Former Director
Director
2010-Present
Chairman, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee
2010-Present
Director
2013-Present
Chairman

Education*

Doctorate
Baylor College of Medicine
BS
Villanova University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$92,500
Total Calculated Compensation$391,038
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NVAX:US $9.02 USD +0.025

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
J. Joseph Kim Ph.D.Chief Executive Officer, President, Director and Member of Finance Committee
Inovio Pharmaceuticals, Inc.
$964.7K
Eddie Gray Chief Executive Officer and Director
Dynavax Technologies Corporation
$515.0K
Stephen T. Isaacs Chairman, Chief Executive Officer and President
Aduro BioTech, Inc.
$886.6K
Daniel J. O'Connor Esq.Chief Executive Officer, President and Director
Advaxis, Inc.
$398.8K
Laurence James Neil Cooper Ph.D., M.D.Chief Executive Officer
ZIOPHARM Oncology, Inc.
--
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVAVAX INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.